awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36372611-2FE4EB5D-EF2A-465D-999C-273CEB963406
Q36372611-2FE4EB5D-EF2A-465D-999C-273CEB963406
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36372611-2FE4EB5D-EF2A-465D-999C-273CEB963406
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
P2860
Q36372611-2FE4EB5D-EF2A-465D-999C-273CEB963406
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36372611-2FE4EB5D-EF2A-465D-999C-273CEB963406
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
795cc500021eb2d623d92575e2a913c6db9c1bba
P2860
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations.